MediciNova, Inc.(NASDAQ : MNOV)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||0.45%||166.93||0.7%||$1253.55m|
|LLY||Eli Lilly & Co.||0.18%||311.43||1.1%||$814.08m|
|BMY||Bristol-Myers Squibb Co.||-0.73%||70.77||1.0%||$778.85m|
|MRK||Merck & Co., Inc.||-0.81%||86.80||0.7%||$691.58m|
|ALNY||Alnylam Pharmaceuticals, Inc.||-0.95%||200.78||8.2%||$207.03m|
|GBT||Global Blood Therapeutics, Inc.||0.03%||67.99||5.4%||$199.71m|
|NVO||Novo Nordisk A/S||-0.40%||97.92||0.1%||$170.11m|
|HZNP||Horizon Therapeutics Plc||0.54%||62.97||5.4%||$156.21m|
|SRPT||Sarepta Therapeutics, Inc.||-2.42%||108.19||12.4%||$128.76m|
MediciNova, Inc. is a biopharmaceutical company, which engages in the acquisition and development of small molecule therapeutics for the treatment of diseases with unmet medical needs. Its development pipeline consists of clinical-stage compounds for the treatment of acute exacerbations of asthma and COPD, progressive multiple sclerosis, methamphetamine addiction, neuropathic pain, asthma, interstitial cystitis, and solid tumor cancers. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA.